Search Results - Pratik S. Multani

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Entrectinib in <i>TRK</i> and <i>ROS1</i> Fusion-Positive Metastatic Pancreatic Cancer

    Entrectinib in <i>TRK</i> and <i>ROS1</i> Fusion-Positive Metastatic Pancreatic Cancer by Michael J. Pishvaian, Ignacio Garrido‐Laguna, Stephen V. Liu, Pratik S. Multani, Edna Chow‐Maneval, Christian Rolfo

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial

    Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial by Gregory A. Wiseman, Leo I. Gordon, Pratik S. Multani, Thomas E. Witzig, Stewart Spies, Nancy L. Bartlett, Russell J. Schilder, James L. Murray, Mansoor N. Saleh, R. S. Allen, Antonio J Grillo-López, Christine A. White

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

    Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for re... by Thomas R. Spitzer, Steven L. McAfee, Robert Sackstein, Christine Colby, Han Chong Toh, Pratik S. Multani, Susan L. Saidman, Dina Weymouth, Frederic I. Preffer, Cathleen Poliquin, Alicia Foley, Benjamin F. Cox, David Andrews, David H. Sachs, Megan Sykes

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations

    Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations by Gang G. Li, Romel Somwar, James D. Joseph, Roger S. Smith, Takuo Hayashi, Leenus Martin, Aleksandra Franovic, Anni Schairer, Eric S. Martin, Gregory J. Riely, Jason Harris, Shunqi Yan, Wei Ge, Jennifer Oliver, Rupal Patel, Pratik S. Multani, Marc Ladanyi, Alexander Drilon

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

    Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer by Alessio Amatu, Alessio Somaschini, Giulio Cerea, Roberta Bosotti, Emanuele Valtorta, Pasquale Buonandi, Giovanna Marrapese, Silvio Veronese, David Luo, Zachary Hornby, Pratik S. Multani, Danielle Murphy, Robert Shoemaker, Calogero Lauricella, Laura Giannetta, M. Maiolani, Angelo Vanzulli, Elena Ardini, Arturo Galvani, Antonella Isacchi, Andrea Sartore‐Bianchi, Salvatore Siena

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

    Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 by George D. Demetri, Luis Paz‐Ares, Anna F. Farago, Stephen V. Liu, Sant P. Chawla, Diégo Tosi, E.S. Kim, Collin M. Blakely, John C. Krauss, Darren Sigal, Lyudmila Bazhenova, Thomas John, Benjamin Besse, J. Wolf, Takashi Seto, Edna Chow‐Maneval, Pratik S. Multani, Ann Johnson, Brian Simmons, Robert C. Doebele

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

    OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) by Robert C. Doebele, Myung‐Ju Ahn, Salvatore Siena, Alexander Drilon, Matthew Krebs, Chung‐Wu Lin, Filippo de Braud, Thomas John, Daniel Shao-Weng Tan, Takashi Seto, Rafał Dziadziuszko, Hendrik‐Tobias Arkenau, Fabrice Barlési, Christian Rolfo, Juergen Wolf, Edna Chow‐Maneval, Pratik S. Multani, Na Cui, Todd Riehl, B.C. Cho

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer

    Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer by Anna F. Farago, Long P. Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish R. Patel, Todd M. Bauer, Stephen V. Liu, Sai‐Hong Ignatius Ou, David M. Jackman, Daniel B. Costa, Pratik S. Multani, Gary G. Li, Zachary Hornby, Edna Chow‐Maneval, David Luo, Jonathan E. Lim, A. John Iafrate, Alice T. Shaw

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement

    Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement by Edward S. Kim, Suanna S. Bruinooge, Samantha Roberts, Gwynn Ison, Nancy U. Lin, Lia Gore, Thomas S. Uldrick, Stuart M. Lichtman, Nancy Roach, Julia A. Beaver, Rajeshwari Sridhara, Paul J. Hesketh, Andrea Denicoff, Elizabeth Garrett‐Mayer, Eric H. Rubin, Pratik S. Multani, Tatiana M. Prowell, Caroline Schenkel, Marina Kozak, Jeffrey C. Allen, Ellen V. Sigal, Richard L. Schilsky

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> Isoforms

    ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> Isoforms by Kasey L. Couts, Judson Bemis, Jacqueline A. Turner, Stacey M. Bagby, Danielle Murphy, Jason Christiansen, Jennifer D. Hintzsche, Anh T. Le, Todd M. Pitts, Keith Wells, Allison Applegate, Carol M. Amato, Pratik S. Multani, Edna Chow‐Maneval, John J. Tentler, Yiqun G. Shellman, Matthew J. Rioth, Aik Choon Tan, René González, Theresa Medina, Robert C. Doebele, William A. Robinson

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

    A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 by Alexander Drilon, Siqing Fu, Manish R. Patel, Marwan Fakih, Ding Wang, Anthony J. Olszanski, Daniel Morgensztern, Stephen V. Liu, Byoung Chul Cho, Lyudmila Bazhenova, Cristina P. Rodriguez, Robert C. Doebele, Antoinette Wozniak, Karen L. Reckamp, Tara Elisabeth Seery, Petros Nikolinakos, Zheyi Hu, Jennifer Oliver, Denise Trone, Katherine McArthur, Rupal Patel, Pratik S. Multani, Myung‐Ju Ahn

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor

    Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor by Christopher Alvarez‐Breckenridge, Julie J. Miller, Naema Nayyar, Corey M. Gill, Andrew Kaneb, Megan R. D’Andrea, Long P. Le, Jesse Lee, Ju Cheng, Zongli Zheng, William E. Butler, Pratik S. Multani, Edna Chow Maneval, Sun Ha Paek, Brian Toyota, Dora Dias‐Santagata, Sandro Santagata, Javier M. Romero, Alice T. Shaw, Anna F. Farago, Stephen Yip, Daniel P. Cahill, Tracy T. Batchelor, A. John Iafrate, Priscilla K. Brastianos

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation

    Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation by Corey Cutler, Pratik S. Multani, David Robbins, Haesook T. Kim, Thuy Le, Jonathan Hoggatt, Louis M. Pelus, Caroline Desponts, Yi‐Bin Chen, Betsy Rezner, Philippe Armand, John Koreth, Brett Glotzbecker, Vincent T. Ho, Edwin P. Alyea, Marlisa Isom, Grace Kao, Myriam Armant, Leslie E. Silberstein, Peirong Hu, Robert J. Soiffer, David T. Scadden, Jerome Ritz, Wolfram Goessling, Trista E. North, John Mendlein, Karen K. Ballen, Leonard I. Zon, Joseph H. Antin, Daniel Shoemaker

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)

    What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC) by Alexander Drilon, G. Li, Snjezana Doğan, Mrinal M. Gounder, Ronglai Shen, Maria E. Arcila, L. Wang, David M. Hyman, Jaclyn F. Hechtman, Wei Ge, Nicholas Cam, Jason Christiansen, Lu Wang, Edna Chow Maneval, Todd M. Bauer, Minesh Patel, Stephen V. Liu, S.-H.I. Ou, Anna F. Farago, Alice T. Shaw, Robert Shoemaker, J. K. Lim, Zachary Hornby, Pratik S. Multani, Marc Ladanyi, Manfred Berger, Nora Katabi, Ronald Ghossein, Alan L. Ho

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

    Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) by Alexander Drilon, Salvatore Siena, Sai‐Hong Ignatius Ou, Manish R. Patel, Myung‐Ju Ahn, Jeeyun Lee, Todd M. Bauer, Anna F. Farago, Jennifer J. Wheler, Stephen V. Liu, Robert C. Doebele, Laura Giannetta, Giulio Cerea, Giovanna Marrapese, Michele Schirru, Alessio Amatu, Katia Bencardino, Laura Palmeri, Andrea Sartore‐Bianchi, Angelo Vanzulli, Sara Cresta, Silvia Damian, Matteo Duca, Elena Ardini, Gang Li, Jason Christiansen, Karey Kowalski, Ann Johnson, Rupal Patel, David Luo, Edna Chow‐Maneval, Zachary Hornby, Pratik S. Multani, Alice T. Shaw, Filippo de Braud

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: